Literature DB >> 23350796

Plasma brain-derived neurotrophic factor and prefrontal white matter integrity in late-onset depression and normal aging.

R B Dalby1, B Elfving, P H P Poulsen, L Foldager, J Frandsen, P Videbech, R Rosenberg.   

Abstract

OBJECTIVE: To explore the relationship between brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF), cerebral deep white matter lesions (DWMLs), and measures of white matter integrity in patients with late-onset depression, with respect to vascular risk factors.
METHOD: We examined 22 patients with late-onset depression and 22 matched controls. Quantification of plasma BDNF and VEGF levels were performed with enzyme-linked immunosorbent assay (ELISA) kits. Measures of white matter integrity comprised apparent diffusion coefficient (ADC) and fractional anisotropy (FA), obtained by diffusion tensor imaging (DTI). Effects of DWMLs, FA, ADC, and vascular risk factors on BDNF and VEGF were assessed using multiple linear regression.
RESULTS: The BDNF and VEGF levels did not differ significantly between groups. With pooled data for patients and controls, the BDNF level was positively associated with both number (t = 2.14, P = 0.039) and volume (t = 2.04, P = 0.048) of prefrontal DWMLs and negatively associated with FA in prefrontal normal-appearing white matter (t = -2.40, P = 0.02), adjusted for age and gender. Smoking and hypercholesterolemia was positively associated with the BDNF (t = 2.36, P = 0.023) and VEGF levels (t = 2.28, P = 0.028), respectively.
CONCLUSION: Our results suggest a role for BDNF in the complex pathophysiologic mechanisms underlying DWMLs in both normal aging and late-onset depression.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BDNF; VEGF; depression; diffusion tensor imaging; white matter lesions

Mesh:

Substances:

Year:  2013        PMID: 23350796     DOI: 10.1111/acps.12085

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  8 in total

1.  Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression.

Authors:  Caren Nádia Soares de Sousa; Lucas Nascimento Meneses; Germana Silva Vasconcelos; Ingridy da Silva Medeiros; Márcia Calheiros Chaves Silva; Fayçal Mouaffak; Oussama Kebir; Cláudio Manuel Gonçalves da Silva Leite; Manoel Cláudio Azevedo Patrocinio; Danielle Macedo; Silvânia Maria Mendes Vasconcelos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-07       Impact factor: 3.000

2.  Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression.

Authors:  Tiffany C Ho; Jing Wu; David D Shin; Thomas T Liu; Susan F Tapert; Guang Yang; Colm G Connolly; Guido K W Frank; Jeffrey E Max; Owen Wolkowitz; Stuart Eisendrath; Fumiko Hoeft; Dipavo Banerjee; Korey Hood; Robert L Hendren; Martin P Paulus; Alan N Simmons; Tony T Yang
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-07-25       Impact factor: 8.829

3.  Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls.

Authors:  Jagadeesh Rao; Joshua Chiappelli; Peter Kochunov; William T Regenold; Stanley I Rapoport; L Elliot Hong
Journal:  Neurodegener Dis       Date:  2014-12-17       Impact factor: 2.977

4.  The Serum BDNF Level Offers Minimum Predictive Value for Motor Function Recovery After Stroke.

Authors:  Wenshu Luo; Tao Liu; Shanshan Li; Hongmei Wen; Fenghua Zhou; Ross Zafonte; Xun Luo; Minghzu Xu; Randie Black-Schaffer; Lisa J Wood; Yulong Wang; Qing Mei Wang
Journal:  Transl Stroke Res       Date:  2018-08-03       Impact factor: 6.829

5.  Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression?

Authors:  Márcia Calheiros Chaves Silva; Caren Nádia Soares de Sousa; Luis Rafael Leite Sampaio; Naiara Coelho Ximenes; Paulo Victor Pontes Araújo; Jéssica Calheiros da Silva; Suzyana Lima de Oliveira; Francisca Cléa Florenço Sousa; Danielle Silveira Macêdo; Silvânia Maria Mendes Vasconcelos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-16       Impact factor: 3.000

Review 6.  Genetics of the connectome.

Authors:  Paul M Thompson; Tian Ge; David C Glahn; Neda Jahanshad; Thomas E Nichols
Journal:  Neuroimage       Date:  2013-05-21       Impact factor: 6.556

7.  The BDNF Val66Met Polymorphism Affects the Vulnerability of the Brain Structural Network.

Authors:  Chang-Hyun Park; Jungyoon Kim; Eun Namgung; Do-Wan Lee; Geon Ha Kim; Myeongju Kim; Nayeon Kim; Tammy D Kim; Seunghee Kim; In Kyoon Lyoo; Sujung Yoon
Journal:  Front Hum Neurosci       Date:  2017-08-03       Impact factor: 3.169

Review 8.  Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer.

Authors:  Luca Colucci-D'Amato; Luisa Speranza; Floriana Volpicelli
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.